Femoral Triangle + IPACK Blocks for ACL Reconstruction Analgesia

Sponsor
University of Chile (Other)
Overall Status
Recruiting
CT.gov ID
NCT05068063
Collaborator
Clinica Alemana de Santiago (Other)
48
2
2
4.5
24
5.4

Study Details

Study Description

Brief Summary

An adequate balance between analgesia and motor function is an essential requirement to facilitate functional recovery and early discharge after anterior cruciate ligament (ACL) reconstruction surgery.

Proximal nerve blocks (i.e. femoral and sciatic nerve blocks) are associated with optimal analgesia, but they can cause muscle weakness, interfering with rehabilitation and increasing the risk of falls .

A recent randomized controlled trial concluded that, compared to mid-and distal ACB, a distal femoral triangle block (FTB) is associated with lower opioid consumption and improved postoperative analgesia for ambulatory ACL reconstruction.

In ACL reconstruction surgery there are other potential sources of pain not covered by a FTB, such as intra-articular structures (menisci, cruciate ligaments), posterior knee capsule and the graft donor site.

Evidence supporting the addition of an IPACK block to a FTB has been studied for patients undergoing total knee replacement, nonetheless, there is no trial analyzing the analgesic contribution of IPACK to a FTB in the context of ACL reconstruction surgery.

In this multicentric trial, the investigators set out to analyze the analgesic benefit of adding an IPACK block to a FTB.

Condition or Disease Intervention/Treatment Phase
  • Drug: Bupivacaine Injection
  • Drug: normal Saline
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomised Comparison Between Combined Femoral Triangle Block+IPACK Block and Femoral Triangle Block for Anterior Cruciate Ligament Reconstruction Analgesia
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Oct 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Femoral Triangle + IPACK block

Patients randomized to receive a combination of femoral triangle block and active IPACK block

Drug: Bupivacaine Injection
Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of Bupivacaine 0.25%

Active Comparator: Femoral Triangle block

Patients randomized to receive a combination of femoral triangle block and sham IPACK block

Drug: normal Saline
Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of normal saline 0.9%

Outcome Measures

Primary Outcome Measures

  1. Post-operative pain scores at 2 hours of arrival to Post Anesthesia Care Unit (PACU) [2 hours after arrival to PACU]

    Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points

Secondary Outcome Measures

  1. Post-operative static pain scores at 0 hours of arrival to PACU [0 hours after arrival to PACU]

    Pain evaluated at rest in Numeric Rating Score from 0 to 10 points

  2. Post-operative static pain scores at PACU discharge [at discharge of PACU up to 2 hours postoperatively]

    Pain evaluated at rest in Numeric Rating Score from 0 to 10 points

  3. Post-operative static pain scores at 6 hours of arrival to PACU [6 hours after arrival to PACU]

    Pain evaluated at rest in Numeric Rating Score from 0 to 10 points

  4. Post-operative static pain scores at 12 hours of arrival to PACU [12 hours after arrival to PACU]

    Pain evaluated at rest in Numeric Rating Score from 0 to 10 points

  5. Post-operative static pain scores at 24 hours of arrival to PACU [24 hours after arrival to PACU]

    Pain evaluated at rest in Numeric Rating Score from 0 to 10 points

  6. Post-operative dynamic pain scores at 0 hours of arrival to PACU [0 hours after arrival to PACU]

    Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points

  7. Post-operative dynamic pain scores at PACU discharge [at discharge of PACU up to 2 hours postoperatively]

    Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points

  8. Post-operative dynamic pain scores at 6 hours of arrival to PACU [6 hours after arrival to PACU]

    Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points

  9. Post-operative dynamic pain scores at 12 hours of arrival to PACU [12 hours after arrival to PACU]

    Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points

  10. Post-operative dynamic pain scores at 24 hours of arrival to PACU [24 hours after arrival to PACU]

    Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points

  11. Femoral Triangle Block success assessment at 2 hours [2 hours after arrival to PACU]

    Sensory block will be assessed with ice on the medial leg

  12. Incidence of opioid related adverse events [24 hours after arrival to PACU]

    Incidence of adverse events related to opioid use (nausea/vomiting, pruritus, somnolence, respiratory depression, urinary retention)

  13. Intraoperative opioid consumption [From anesthesia induction to extubation]

    Total opioid use during intraoperative period

  14. PACU opioid consumption [from PACU arrival to discharge up to 2 hours postoperatively]

    total opioid consumption during PACU stay

  15. Total opioid consumption [6 hours, 12 hours and 24 hours after PACU arrival]

    Total opioid consumption

  16. Nerve block complications [From nerve block performance up to 24 hours after PACU arrival]

    Incidence of nerve block complications (vascular puncture, puncture site erythema, hematoma, foot drop, LAST)

  17. Lower limb tourniquet [from inflation of pneumatic device to tourniquet release]

    lower limb tourniquet duration

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient scheduled to undergo anterior cruciate ligament reconstruction under general anesthesia with ipsilateral autologous graft.

  • Age between 18 and 65 years

  • American Society of Anesthesiologists classification 1-3

  • Body mass index between 19 and 35 (kg/m2)

Exclusion Criteria:
  • Adults who are unable to give their own consent

  • Pre-existing neuropathy (assessed by history and physical examination)

  • Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or prothrombin time ≥ 50)

  • Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)

  • Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)

  • Allergy to local anesthetics (LAs), morphine or tramadol

  • Pregnancy

  • ACL revision surgery

  • Contralateral graft or any type of allograft

  • Chronic pain syndromes requiring opioid intake at home

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinica Alemana de Santiago Santiago RM Chile
2 Hospital Clinico Universidad de Chile Santiago RM Chile

Sponsors and Collaborators

  • University of Chile
  • Clinica Alemana de Santiago

Investigators

  • Principal Investigator: Andrea Gonzalez, MD, Clinica Alemana de Santiago

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sebastian Layera, Assistant Professor, University of Chile
ClinicalTrials.gov Identifier:
NCT05068063
Other Study ID Numbers:
  • IPACK1
First Posted:
Oct 5, 2021
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sebastian Layera, Assistant Professor, University of Chile
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2022